Tag archief: Standard

NetApp en Equinix leveren de meest uitgebreide Bare Metal-as-a-Service-oplossing in de branche voor Cloud Adjacent Experience

NetApp Storage op Equinix Metal, ondersteund door NetApp Keystone, stelt organisaties in staat bedrijfskritische workloads te leveren met een complete stackoplossing as-a-service. SAN JOSE, Calif.–(BUSINESS...

Vraag naar IT- en business services in Europa gedaald in het derde kwartaal, aldus ISG Index™

Beheerde services gedaald met 2%, terwijl XaaS met 8% daalt ten opzichte van vorig jaar LONDEN–(BUSINESS WIRE)– De algehele vraag naar IT- en business services...

PUMA Celebrates the Anniversary of Tommie Smith’s Iconic Gesture at the 1968 Olympics

HERZOGENAURACH, Germany–(BUSINESS WIRE)– Global sports company PUMA celebrates 55 years since the iconic Silent Gesture made by Tommie Smith at the 1968 Olympics on October...

Creation of Next Generation Private Equity Firm, New Private Equity

Renowned investing and operational industry veterans combine with technology pioneer Palantir to create a next generation private equity firm MIAMI–(BUSINESS WIRE)– Gero Wittemann and Francesco...

NetApp and Equinix Deliver Industry’s Most Comprehensive Bare Metal-as-a-Service Solution for Cloud Adjacent Experience

NetApp Storage on Equinix Metal, powered by NetApp Keystone, lets organizations power business-critical workloads with a full stack solution as-a-service. SAN JOSE, Calif.–(BUSINESS WIRE)– NetApp®...

Incyte Announces New Data from across its Oncology Portfolio to be Presented at ESMO Congress 2023

WILMINGTON, Del.–(BUSINESS WIRE)– Incyte (Nasdaq:INCY) today announced that abstracts featuring new data from its oncology portfolio will be presented at the upcoming European Society for...

Voormalig CEO Vodafone Duitsland Dr. Hannes Ametsreiter treedt toe tot raad van bestuur van Technology Telco 1GLOBAL

LONDEN–(BUSINESS WIRE)– Het voormalige hoofd van Vodafone Duitsland, Dr. Hannes Ametsreiter, is toegetreden tot de raad van bestuur van het telecommunicatiebedrijf 1GLOBAL als niet-uitvoerend bestuurder...

Exscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ESMO 2023

— Demonstrated preclinical efficacy of LSD1 inhibitor in primary AML samples — — Initial data supporting combination potential of LSD1 inhibitor with AML standard of...

Digital Check Corp. Introduces Two Next-Generation Check Scanners for the Global Market

NORTHBROOK, Ill.–(BUSINESS WIRE)– Digital Check Corp., the world’s largest manufacturer of check scanners and related technology, announced two major new products that continue the legacy...

Former Vodafone Germany CEO Dr Hannes Ametsreiter Joins Board of Technology Telco 1GLOBAL

LONDON–(BUSINESS WIRE)– The former head of Vodafone Germany, Dr. Hannes Ametsreiter, has joined the board of the telecommunications company 1GLOBAL as non-executive director following his...

Demand for IT and Business Services in Europe Down in Q3, ISG Index™ Finds

Managed services down 2%, while XaaS drops 8% vs. prior year LONDON–(BUSINESS WIRE)– Overall demand for IT and business services in Europe fell by single...

Incyte kondigt nieuwe gegevens aan voor ruxolitinib-crème (Opzelura®) bij kinderen met atopische dermatitis

– Tijdens het TRuE-AD3-onderzoek behaalsen kinderen (van ≥2 tot <12 jaar oud) met atopische dermatitis (AD) behandeld met ruxolitinib-crème een aanzienlijke efficiëntie, zoals gedefinieerd door...

Mundipharma en Cidara Therapeutics ontvangen positief CHMP-advies voor rezafungine voor de behandeling van invasieve candidiasis bij volwassenen1

Alleen voor handels- en medische media Het advies was gebaseerd op positieve resultaten van de cruciale ReSTORE fase III klinische studie en werd ondersteund door...

Incyte Announces New Data for Ruxolitinib Cream (Opzelura®) in Children with Atopic Dermatitis

– In the TRuE-AD3 trial, children (age ≥2 to <12 years old) with atopic dermatitis (AD) treated with ruxolitinib cream achieved significant efficacy, as defined...

Mundipharma and Cidara Therapeutics receive positive CHMP opinion for rezafungin for the treatment of Invasive Candidiasis in adults1

For Trade and Medical Media Only The opinion was based on positive results from the pivotal ReSTORE Phase III clinical trial and supported by the...